Elah Feder
Audio Producer and Editor at Freelance
Audio producer at large. Formerly @SciFri, #sciencediction, and @undiscovered
Articles
-
Nov 23, 2024 |
scientificamerican.com | Josh Fischman |Tanya Lewis |Elah Feder
Tanya Lewis: Hi, this is Your Health, Quickly, a Scientific American podcast series!Josh Fischman: We bring you the latest vital health news: Discoveries that affect your body and your mind. Lewis: And we break down the medical research to help you stay healthy. I’m Tanya Lewis. Fischman: I’m Josh Fischman. Lewis: We’re Scientific American’s senior health editors.
-
Oct 10, 2024 |
scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger
It’s September 2024, and a group of American thalidomide survivors and their family members arrive in Washington, D.C., to lobby the government for support. More than 60 years have gone by since Food and Drug Administration medical examiner Frances Oldham Kelsey first stalled the new drug application for thalidomide from the pharmaceutical company Richardson-Merrell.
-
Oct 3, 2024 |
scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger
It’s the summer of 1962, and the drug thalidomide has been off the market in Europe for months after it was determined to be unsafe to use during pregnancy. But in the U.S., people are only just beginning to find out about the scandal. The Washington Post breaks the story and puts a picture of Food and Drug Administration medical examiner Frances Oldham Kelsey, who refused to approve the medication, on the front page. She’s the hero who saved American lives. President John F.
-
Sep 26, 2024 |
scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger
It’s the early 1960s, and Widukind Lenz, a German pediatrician, is going door to door in his efforts to find out what is causing an epidemic of babies born with shortened limbs and other serious medical conditions. In the U.S. the drug company Richardson-Merrell is battling with Frances Oldham Kelsey at the Food and Drug Administration about the pending approval of thalidomide. She’s asking for data that show it’s safe to use during pregnancy (spoiler alert: it’s not).
-
Sep 19, 2024 |
scientificamerican.com | Katie Hafner |Sarah Wyman |Elah Feder
It’s the early 1960s, and the German pharmaceutical market is booming. A sedative called Contergan is one of the best-selling drugs. Contergan’s active ingredient is thalidomide, and it is touted as a wonder drug, a nonaddictive sedative that is safer than barbiturates. In the U.S. the drug is called Kevadon, and its distributor is impatient to get it on the market.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- No
Breaking my long-standing policy of aggressive Twitter silence to share that I'm working on this, and it's going to be SO GOOD
Today was a BIG day! I'm stoked to share I'm the host of a new podcast called The TED AI Show. I also had the chance to co-host a "mind expanding" session on the TED2024 stage with the one and only @TEDchris featuring the likes of @vkhosla, @drfeifei, @ashtom, @hlntnr and more. https://t.co/xOp1eK2GaC
RT @stuartboersma: I was interviewed for this great podcast on Elizebeth Smith Friedman. Thanks @ElahFeder for the great conversation! @jf…
RT @zoekurland: Hi! I produced this season with the very wonderful @NoraMathison @ElahFeder and the rest of the @LostWomenofSci team. We'v…
